Newly Developed Semi-Synthetic Chloroquine and Hydroxychloroquine-Phytochemical Conjugates as Prospective COVID-19 Drug(s)
Preprints are manuscripts made publicly available before they have been submitted for formal peer review and publication. They might contain new research findings or data. Preprints can be a draft or final version of an author's research but must not have been accepted for publication at the time of submission.
Kindly find a research article entitled “Newly developed semi-synthetic chloroquine and hydroxychloroquine-phytochemical conjugates as prospective COVID-19 drug(s)”, submitted for consideration for publication. Kindly find the Herein, two series of chloroquine (CQ) and hydroxychloroquine (HCQ) derivatives were chemically conjugated with established small phenolic phytochemicals namely, thymol, vanillin, guaiacol, eugenol, 4-hydroxycoumarin and vanillin analogues by the principles of Williamson ether reaction. The HCQ-vanillin conjugation would be coveted as a potential candidate against human COVID-19.
Rabindra Nath Padhy, PhD, Post-Doc, Member NAMS.
Professor and Head, Central Research Laboratory, IMS & Sum Hospital,
Siksha ‘O’ AnusandhanDeemed to be University,
Bhubaneswar- 751003, Odisha, India.